HANDBOOK OF GENERAL MEDICINE VOL 1:@0.076190:0.972666:0.349932:0.972666:0.349932:0.958637:0.076190:0.958637:0.009179:0.009945:0.009945:0.009999:0.007714:0.011679:0.011679:0.007943:0.003723:0.011679:0.006518:0.003723:0.011719:0.007203:0.009945:0.007203:0.008158:0.009945:0.006209:0.003723:0.012351:0.007203:0.009999:0.003037:0.010926:0.003037:0.009945:0.007203:0.003723:0.009434:0.011679:0.006209:0.003723:0.007445
180:@0.078769:0.033217:0.109813:0.033217:0.109813:0.013052:0.078769:0.013052:0.010348:0.010348:0.010348
TREATMENT AppROACHEs:@0.397030:0.032906:0.624375:0.032906:0.624375:0.013617:0.397030:0.013617:0.007872:0.011217:0.009905:0.013674:0.007872:0.016982:0.009905:0.013674:0.007872:0.005119:0.013674:0.010939:0.010939:0.011217:0.016058:0.013674:0.015023:0.012621:0.009905:0.009202
potentially toxic drugs, in particular corticosteroids, should :@0.076190:0.084931:0.485115:0.084931:0.485115:0.069149:0.076190:0.069149:0.010009:0.009601:0.004823:0.009525:0.008920:0.004823:0.002721:0.010024:0.002721:0.002721:0.007801:0.004022:0.004823:0.009601:0.006955:0.002721:0.009480:0.004022:0.010054:0.004248:0.008890:0.009873:0.005564:0.003886:0.004022:0.002721:0.008920:0.004022:0.010009:0.010024:0.004248:0.004823:0.002721:0.009480:0.008890:0.002721:0.010024:0.004248:0.004022:0.009480:0.009601:0.004248:0.004823:0.002721:0.009480:0.009601:0.005564:0.004823:0.009525:0.004248:0.009601:0.002721:0.010054:0.005564:0.003886:0.004022:0.005564:0.008920:0.009601:0.008890:0.002721:0.010357:0.004188
be avoided where the diagnosis is unclear. Fortunately, :@0.076190:0.098451:0.485145:0.098451:0.485145:0.082668:0.076190:0.082668:0.010009:0.009525:0.006259:0.010024:0.008074:0.009601:0.002721:0.010054:0.009525:0.010054:0.006259:0.012262:0.008920:0.009525:0.004248:0.009525:0.006259:0.004823:0.008920:0.009525:0.006259:0.010054:0.002721:0.010024:0.009873:0.008920:0.009601:0.005564:0.002721:0.005564:0.006259:0.002721:0.005564:0.006259:0.008890:0.008920:0.009480:0.002721:0.009525:0.010024:0.004248:0.003886:0.006259:0.007030:0.009601:0.004248:0.004823:0.008890:0.008920:0.010024:0.004823:0.009525:0.002721:0.007801:0.004188:0.004188
patients with ill-defined rheumatic symptoms seldom pro:@0.076190:0.111971:0.476240:0.111971:0.476240:0.096188:0.076190:0.096188:0.010009:0.010024:0.004823:0.002721:0.009525:0.008920:0.004823:0.005564:0.004626:0.012262:0.002721:0.004823:0.008920:0.004626:0.002721:0.002721:0.002721:0.004717:0.010054:0.009525:0.003530:0.003530:0.008920:0.009525:0.010054:0.004626:0.004248:0.008920:0.009525:0.008890:0.013879:0.010024:0.004823:0.002721:0.009480:0.004626:0.005564:0.007801:0.013879:0.010009:0.004823:0.009601:0.013879:0.005564:0.004626:0.005564:0.009525:0.002721:0.010054:0.009601:0.013879:0.004626:0.010009:0.004248:0.009903
-:@0.475938:0.111971:0.480957:0.111971:0.480957:0.096188:0.475938:0.096188:0.005020
gress to develop serious complications or disability.:@0.076190:0.125490:0.431064:0.125490:0.431064:0.109708:0.076190:0.109708:0.009873:0.004248:0.009525:0.005564:0.005564:0.003886:0.004823:0.009601:0.003886:0.010054:0.009525:0.008074:0.009525:0.002721:0.009601:0.010009:0.003886:0.005564:0.009525:0.004248:0.002721:0.009601:0.008890:0.005564:0.003886:0.009480:0.009601:0.013879:0.010009:0.002721:0.002721:0.009480:0.010024:0.004823:0.002721:0.009601:0.008920:0.005564:0.003886:0.009601:0.004248:0.003886:0.010054:0.002721:0.005564:0.010024:0.010009:0.002721:0.002721:0.002721:0.004823:0.007801:0.004188
13:@0.430758:0.120182:0.440299:0.120182:0.440299:0.111029:0.430758:0.111029:0.004683:0.004858
The  overarching  principle  in  inflammatory  arthritis :@0.090476:0.138998:0.485144:0.138998:0.485144:0.123215:0.090476:0.123215:0.006441:0.009223:0.009827:0.004188:0.006531:0.009903:0.008376:0.009827:0.004551:0.010326:0.004551:0.009782:0.009223:0.003024:0.009223:0.010175:0.004188:0.006531:0.010311:0.004551:0.003024:0.009223:0.009782:0.003024:0.010311:0.003024:0.009827:0.004188:0.006547:0.003024:0.009223:0.004188:0.006531:0.003024:0.009223:0.003666:0.003666:0.010326:0.014182:0.014182:0.010326:0.005125:0.009903:0.004551:0.008104:0.004188:0.006531:0.010326:0.004551:0.005125:0.009223:0.004551:0.003024:0.005125:0.003024:0.005866:0.004188
management is goal-directed therapy. This is well estab-:@0.076189:0.152517:0.480956:0.152517:0.480956:0.136735:0.076189:0.136735:0.014182:0.010326:0.009223:0.010326:0.010175:0.009827:0.014182:0.009827:0.009223:0.005125:0.003160:0.003024:0.005866:0.003160:0.010175:0.009903:0.010326:0.003024:0.005020:0.010357:0.003024:0.004551:0.009827:0.009782:0.005125:0.009827:0.010357:0.003160:0.005125:0.009223:0.009827:0.004551:0.010326:0.010311:0.008104:0.004188:0.003160:0.006441:0.009223:0.003024:0.005866:0.003160:0.003024:0.005866:0.003175:0.012564:0.009827:0.003024:0.003024:0.003175:0.009827:0.005866:0.005125:0.010326:0.010311:0.005020
lished in RA where the “treat to target” strategy is widely :@0.076189:0.166037:0.485128:0.166037:0.485128:0.150255:0.076189:0.150255:0.003024:0.003024:0.005866:0.009223:0.009827:0.010357:0.003583:0.003024:0.009223:0.003583:0.009177:0.011188:0.003568:0.012564:0.009223:0.009827:0.004551:0.009827:0.003568:0.005125:0.009223:0.009827:0.003568:0.007590:0.005125:0.004551:0.009827:0.010326:0.005125:0.003568:0.005125:0.009903:0.003583:0.005125:0.010326:0.004551:0.010175:0.009827:0.005125:0.007318:0.003568:0.005866:0.005125:0.004551:0.010326:0.005125:0.009827:0.010175:0.008104:0.003568:0.003024:0.005866:0.003583:0.012564:0.003024:0.010357:0.009827:0.003024:0.008104:0.004188
accepted. Evidence suggests that obtaining tight con-:@0.076189:0.179557:0.480940:0.179557:0.480940:0.163774:0.076189:0.163774:0.010326:0.009782:0.009782:0.009827:0.010311:0.005125:0.009827:0.010357:0.004188:0.004642:0.008104:0.008376:0.003024:0.010372:0.009827:0.009223:0.009782:0.009827:0.004642:0.005866:0.009192:0.010175:0.010175:0.009827:0.005866:0.005125:0.005866:0.004657:0.005125:0.009223:0.010326:0.005125:0.004642:0.009903:0.010311:0.005125:0.010326:0.003024:0.009223:0.003024:0.009223:0.010175:0.004642:0.005125:0.003024:0.010175:0.009223:0.005125:0.004642:0.009782:0.009903:0.009223:0.005020
trol of disease, with a pre-defined goal of remission or :@0.076189:0.193077:0.485144:0.193077:0.485144:0.177294:0.076189:0.177294:0.005125:0.004551:0.009903:0.003024:0.005912:0.009903:0.004747:0.005927:0.010357:0.003024:0.005866:0.009827:0.010326:0.005866:0.009827:0.004188:0.005927:0.012564:0.003024:0.005125:0.009223:0.005927:0.010326:0.005927:0.010311:0.004551:0.009827:0.005020:0.010357:0.009827:0.003681:0.003681:0.009223:0.009827:0.010357:0.005912:0.010175:0.009903:0.010326:0.003024:0.005927:0.009903:0.004747:0.005927:0.004551:0.009827:0.014182:0.003024:0.005866:0.005866:0.003024:0.009903:0.009223:0.005927:0.009903:0.004551:0.004188
low disease activity to drive disease-management de-:@0.076189:0.206596:0.480940:0.206596:0.480940:0.190814:0.076189:0.190814:0.003024:0.009903:0.012564:0.005397:0.010357:0.003024:0.005866:0.009827:0.010326:0.005866:0.009827:0.005397:0.010326:0.009782:0.005125:0.003024:0.008376:0.003024:0.005125:0.008104:0.005397:0.005125:0.009903:0.005397:0.010357:0.004551:0.003024:0.008376:0.009827:0.005397:0.010357:0.003024:0.005866:0.009827:0.010326:0.005866:0.009827:0.005020:0.014182:0.010326:0.009223:0.010326:0.010175:0.009827:0.014182:0.009827:0.009223:0.005125:0.005397:0.010357:0.009827:0.005020
cisions, allows for better control of disease than routine :@0.076189:0.220116:0.485159:0.220116:0.485159:0.204333:0.076189:0.204333:0.009782:0.003024:0.005866:0.003024:0.009903:0.009223:0.005866:0.004188:0.004914:0.010326:0.003024:0.003024:0.009903:0.012564:0.005866:0.004914:0.004747:0.009903:0.004551:0.004899:0.010311:0.009827:0.005125:0.005125:0.009827:0.004551:0.004899:0.009782:0.009903:0.009223:0.005125:0.004551:0.009903:0.003024:0.004899:0.009903:0.004747:0.004899:0.010357:0.003024:0.005866:0.009827:0.010326:0.005866:0.009827:0.004914:0.005125:0.009223:0.010326:0.009223:0.004899:0.004551:0.009903:0.009192:0.005125:0.003024:0.009223:0.009827:0.004188
clinic care. Disease activity is assessed by joint counts, :@0.076189:0.233636:0.485113:0.233636:0.485113:0.217853:0.076189:0.217853:0.009782:0.003024:0.003024:0.009223:0.003024:0.009782:0.005579:0.009782:0.010326:0.004551:0.009827:0.004188:0.005564:0.011249:0.003024:0.005866:0.009827:0.010326:0.005866:0.009827:0.005579:0.010326:0.009782:0.005125:0.003024:0.008376:0.003024:0.005125:0.008104:0.005579:0.003024:0.005866:0.005579:0.010326:0.005866:0.005866:0.009827:0.005866:0.005866:0.009827:0.010357:0.005579:0.010311:0.008104:0.005579:0.003069:0.009903:0.003024:0.009223:0.005125:0.005564:0.009782:0.009903:0.009192:0.009223:0.005125:0.005866:0.004188:0.004188
inflammatory  markers  and  questionnaires  to  assess :@0.076189:0.247155:0.485144:0.247155:0.485144:0.231373:0.076189:0.231373:0.003024:0.009223:0.003666:0.003666:0.010326:0.014182:0.014182:0.010326:0.005125:0.009903:0.004551:0.008104:0.004188:0.007363:0.014182:0.010326:0.004551:0.007590:0.009827:0.004551:0.005866:0.004188:0.007363:0.010326:0.009223:0.010357:0.004188:0.007363:0.010311:0.009192:0.009827:0.005866:0.005125:0.003024:0.009903:0.009223:0.009223:0.010326:0.003024:0.004551:0.009827:0.005866:0.004188:0.007363:0.005125:0.009903:0.004188:0.007363:0.010326:0.005866:0.005866:0.009827:0.005866:0.005866:0.004188
functional status. This intensive control strategy results in :@0.076189:0.260675:0.485113:0.260675:0.485113:0.244893:0.076189:0.244893:0.004747:0.009192:0.009223:0.009782:0.005125:0.003024:0.009903:0.009223:0.010326:0.003024:0.004445:0.005866:0.005125:0.010326:0.005125:0.009192:0.005866:0.004188:0.004445:0.006441:0.009223:0.003024:0.005866:0.004445:0.003024:0.009223:0.005125:0.009827:0.009223:0.005866:0.003024:0.008376:0.009827:0.004445:0.009782:0.009903:0.009223:0.005125:0.004551:0.009903:0.003024:0.004430:0.005866:0.005125:0.004551:0.010326:0.005125:0.009827:0.010175:0.008104:0.004445:0.004551:0.009827:0.005866:0.009192:0.003024:0.005125:0.005866:0.004445:0.003024:0.009223:0.004188
lower disease activity, better physical function and less :@0.076189:0.274195:0.485144:0.274195:0.485144:0.258412:0.076189:0.258412:0.003024:0.009903:0.012564:0.009827:0.004551:0.004793:0.010357:0.003024:0.005866:0.009827:0.010326:0.005866:0.009827:0.004808:0.010326:0.009782:0.005125:0.003024:0.008376:0.003024:0.005125:0.008104:0.004188:0.004808:0.010311:0.009827:0.005125:0.005125:0.009827:0.004551:0.004793:0.010311:0.009223:0.008104:0.005866:0.003024:0.009782:0.010326:0.003024:0.004808:0.004747:0.009192:0.009223:0.009782:0.005125:0.003024:0.009903:0.009223:0.004793:0.010326:0.009223:0.010357:0.004793:0.003024:0.009827:0.005866:0.005866:0.004188
structural damage, particularly when commenced ear-:@0.076189:0.287715:0.480940:0.287715:0.480940:0.271932:0.076189:0.271932:0.005866:0.005125:0.004551:0.009192:0.009782:0.005125:0.009192:0.004551:0.010326:0.003024:0.003931:0.010357:0.010326:0.014182:0.010326:0.010175:0.009827:0.004188:0.003931:0.010311:0.010326:0.004551:0.005125:0.003024:0.009782:0.009192:0.003024:0.010326:0.004551:0.003024:0.008104:0.003946:0.012564:0.009223:0.009827:0.009223:0.003931:0.009782:0.009903:0.014182:0.014182:0.009827:0.009223:0.009782:0.009827:0.010357:0.003931:0.009827:0.010326:0.004551:0.005020
ly. This strategy is increasingly being explored with other :@0.076189:0.301234:0.485151:0.301197:0.485151:0.285414:0.076189:0.285452:0.003024:0.008104:0.004188:0.002547:0.006441:0.009223:0.003024:0.005866:0.004581:0.005866:0.005125:0.004551:0.010326:0.005125:0.009827:0.010175:0.008104:0.004566:0.003024:0.005866:0.004581:0.003024:0.009223:0.009782:0.004551:0.009827:0.010326:0.005866:0.003024:0.009223:0.010175:0.003024:0.008104:0.004581:0.010311:0.009827:0.003024:0.009223:0.010175:0.004581:0.009827:0.007257:0.010311:0.003024:0.009903:0.004551:0.009827:0.010357:0.004566:0.012564:0.003024:0.005125:0.009223:0.004581:0.009903:0.005125:0.009223:0.009827:0.004551:0.454804
 :@0.091509:0.299621:0.093835:0.299621:0.093835:0.290853:0.091509:0.290853:0.002327
studies on inflammatory arthritis. :@0.076196:0.314716:0.312612:0.314716:0.312612:0.298934:0.076196:0.298934:0.005866:0.005125:0.009192:0.010357:0.003024:0.009827:0.005866:0.004188:0.009903:0.009223:0.004188:0.003024:0.009223:0.003666:0.003666:0.010326:0.014182:0.014182:0.010326:0.005125:0.009903:0.004551:0.008104:0.004188:0.010326:0.004551:0.005125:0.009223:0.004551:0.003024:0.005125:0.003024:0.005866:0.004188:0.004188
A practical approach to the management of inflam:@0.090483:0.328236:0.475943:0.328236:0.475943:0.312454:0.090483:0.312454:0.011188:0.004702:0.010311:0.004551:0.010326:0.009782:0.005125:0.003024:0.009782:0.010326:0.003024:0.004717:0.010326:0.010311:0.010311:0.004551:0.009903:0.010326:0.009782:0.009223:0.004702:0.005125:0.009903:0.004702:0.005125:0.009223:0.009827:0.004702:0.014182:0.010326:0.009223:0.010326:0.010175:0.009827:0.014182:0.009827:0.009223:0.005125:0.004702:0.009903:0.004747:0.004702:0.003024:0.009223:0.003666:0.003666:0.010326:0.014182
-:@0.475943:0.328236:0.480963:0.328236:0.480963:0.312454:0.475943:0.312454:0.005020
matory arthritis is summarised below::@0.076196:0.341756:0.342034:0.341756:0.342034:0.325973:0.076196:0.325973:0.014182:0.010326:0.005125:0.009903:0.004551:0.008104:0.004188:0.010326:0.004551:0.005125:0.009223:0.004551:0.003024:0.005125:0.003024:0.005866:0.004188:0.003024:0.005866:0.004188:0.005866:0.009192:0.014182:0.014182:0.010326:0.004551:0.003024:0.005866:0.009827:0.010357:0.004188:0.010311:0.009827:0.003024:0.009903:0.012564:0.004188
Initial  treatment  should  control  pain  and  inflamma:@0.090483:0.355276:0.475928:0.355276:0.475928:0.339493:0.090483:0.339493:0.003417:0.009223:0.003024:0.005125:0.003024:0.010326:0.003024:0.004188:0.003235:0.005125:0.004551:0.009827:0.010326:0.005125:0.014182:0.009827:0.009223:0.005125:0.004188:0.003220:0.005866:0.009223:0.009903:0.009192:0.003024:0.010357:0.004188:0.003235:0.009782:0.009903:0.009223:0.005125:0.004551:0.009903:0.003024:0.004188:0.003220:0.010311:0.010326:0.003024:0.009223:0.004188:0.003235:0.010326:0.009223:0.010357:0.004188:0.003235:0.003024:0.009223:0.003666:0.003666:0.010326:0.014182:0.014182:0.010326
-:@0.475928:0.355276:0.480948:0.355276:0.480948:0.339493:0.475928:0.339493:0.005020
tion. Nonsteroidal anti-inflammatory drugs (NSAIDs), to:@0.076196:0.368795:0.475958:0.368795:0.475958:0.353013:0.076196:0.353013:0.005125:0.003024:0.009903:0.009223:0.004188:0.005201:0.011188:0.009903:0.009223:0.005866:0.005125:0.009827:0.004551:0.009903:0.003024:0.010357:0.010326:0.003024:0.005216:0.010326:0.009223:0.005125:0.003024:0.005020:0.003024:0.009223:0.003666:0.003666:0.010326:0.014182:0.014182:0.010326:0.005125:0.009903:0.004551:0.008104:0.005201:0.010357:0.004551:0.009192:0.010175:0.005866:0.005201:0.005579:0.011188:0.007529:0.011188:0.003417:0.011249:0.005866:0.005579:0.004188:0.005216:0.005125:0.009903
-:@0.475958:0.368795:0.480978:0.368795:0.480978:0.353013:0.475958:0.353013:0.005020
gether with simple analgesics such as paracetamol, are :@0.076196:0.382315:0.485151:0.382315:0.485151:0.366532:0.076196:0.366532:0.010175:0.009827:0.005125:0.009223:0.009827:0.004551:0.003644:0.012564:0.003024:0.005125:0.009223:0.003659:0.005866:0.003024:0.014182:0.010311:0.003024:0.009827:0.003659:0.010326:0.009223:0.010326:0.003024:0.010175:0.009827:0.005866:0.003024:0.009782:0.005866:0.003659:0.005866:0.009192:0.009782:0.009223:0.003659:0.010326:0.005866:0.003659:0.010311:0.010326:0.004551:0.010326:0.009782:0.009827:0.005125:0.010326:0.014182:0.009903:0.003024:0.004188:0.003659:0.010326:0.004551:0.009827:0.004188
used first-line. :@0.076196:0.395835:0.177025:0.395835:0.177025:0.380052:0.076196:0.380052:0.009192:0.005866:0.009827:0.010357:0.004188:0.003681:0.003681:0.004551:0.005866:0.005125:0.005020:0.003024:0.003024:0.009223:0.009827:0.004188:0.004188
Introduce  DMARDs early,  ideally within  six weeks  of :@0.090483:0.409355:0.485136:0.409355:0.485136:0.393572:0.090483:0.393572:0.003417:0.009223:0.005125:0.004551:0.009903:0.010357:0.009192:0.009782:0.009827:0.004188:0.002963:0.011249:0.013894:0.011188:0.009177:0.011249:0.005866:0.007166:0.009827:0.010326:0.004551:0.003024:0.008104:0.004188:0.004188:0.002963:0.003024:0.010357:0.009827:0.010326:0.003024:0.003024:0.008104:0.007166:0.012564:0.003024:0.005125:0.009223:0.003024:0.009223:0.004188:0.002963:0.005866:0.003024:0.007257:0.007166:0.012564:0.009827:0.009827:0.007590:0.005866:0.004188:0.002963:0.009903:0.004747:0.004188
symptom onset and by a rheumatologist or experi-:@0.076196:0.422874:0.480948:0.422874:0.480948:0.407092:0.076196:0.407092:0.005866:0.008104:0.014182:0.010311:0.005125:0.009903:0.014182:0.009253:0.009903:0.009223:0.005866:0.009827:0.005125:0.009253:0.010326:0.009223:0.010357:0.009253:0.010311:0.008104:0.009253:0.010326:0.009253:0.004551:0.009223:0.009827:0.009192:0.014182:0.010326:0.005125:0.009903:0.003024:0.009903:0.010175:0.003024:0.005866:0.005125:0.009253:0.009903:0.004551:0.009253:0.009827:0.007257:0.010311:0.009827:0.004551:0.003024:0.005020
enced physician.:@0.076196:0.436394:0.202470:0.436394:0.202470:0.420611:0.076196:0.420611:0.009827:0.009223:0.009782:0.009827:0.010357:0.004188:0.010311:0.009223:0.008104:0.005866:0.003024:0.009782:0.003024:0.010326:0.009223:0.004188
Initially, follow-up visits should be frequent  (one-  to :@0.090483:0.449914:0.485151:0.449914:0.485151:0.434131:0.090483:0.434131:0.003417:0.009223:0.003024:0.005125:0.003024:0.010326:0.003024:0.003024:0.008104:0.004188:0.007711:0.004747:0.009903:0.003024:0.003024:0.009903:0.012564:0.005020:0.009192:0.010311:0.007711:0.008376:0.003024:0.005866:0.003024:0.005125:0.005866:0.007711:0.005866:0.009223:0.009903:0.009192:0.003024:0.010357:0.007711:0.010311:0.009827:0.007711:0.004747:0.004551:0.009827:0.010311:0.009192:0.009827:0.009223:0.005125:0.004188:0.003508:0.005579:0.009903:0.009223:0.009827:0.005020:0.004188:0.003508:0.005125:0.009903:0.004188
three-monthly) to assess drug tolerability and safety, as :@0.076196:0.463433:0.485151:0.463433:0.485151:0.447651:0.076196:0.447651:0.005125:0.009223:0.004551:0.009827:0.009827:0.005020:0.014182:0.009903:0.009223:0.005125:0.009223:0.003024:0.008104:0.005579:0.004883:0.005125:0.009903:0.004883:0.010326:0.005866:0.005866:0.009827:0.005866:0.005866:0.004899:0.010357:0.004551:0.009192:0.010175:0.004899:0.005125:0.009903:0.003024:0.009827:0.004551:0.010326:0.010311:0.003024:0.003024:0.003024:0.005125:0.008104:0.004899:0.010326:0.009223:0.010357:0.004899:0.005866:0.010326:0.004747:0.009827:0.005125:0.008104:0.004188:0.004899:0.010326:0.005866:0.004188
well as response to treatment. Doses can be escalated :@0.076196:0.476953:0.485136:0.476953:0.485136:0.461170:0.076196:0.461170:0.012564:0.009827:0.003024:0.003024:0.004460:0.010326:0.005866:0.004460:0.004551:0.009827:0.005866:0.010311:0.009903:0.009223:0.005866:0.009827:0.004445:0.005125:0.009903:0.004445:0.005125:0.004551:0.009827:0.010326:0.005125:0.014182:0.009827:0.009223:0.005125:0.004188:0.004430:0.011249:0.009903:0.005866:0.009827:0.005866:0.004445:0.009782:0.010326:0.009223:0.004445:0.010311:0.009827:0.004445:0.009827:0.005866:0.009782:0.010326:0.003024:0.010326:0.005125:0.009827:0.010357:0.004188
and treatment added to achieve a target of low dis-:@0.076196:0.490473:0.480948:0.490473:0.480948:0.474690:0.076196:0.474690:0.010326:0.009223:0.010357:0.006123:0.005125:0.004551:0.009812:0.010326:0.005125:0.014182:0.009827:0.009223:0.005125:0.006108:0.010326:0.010357:0.010357:0.009827:0.010357:0.006123:0.005125:0.009903:0.006108:0.010326:0.009782:0.009223:0.003024:0.009827:0.008376:0.009827:0.006123:0.010326:0.006123:0.005125:0.010326:0.004551:0.010175:0.009827:0.005125:0.006108:0.009903:0.004747:0.006108:0.003024:0.009903:0.012564:0.006123:0.010357:0.003024:0.005866:0.005020
ease activity. Once stable, four to six-monthly visits are :@0.076196:0.503993:0.485136:0.503993:0.485136:0.488210:0.076196:0.488210:0.009827:0.010326:0.005866:0.009827:0.005231:0.010326:0.009782:0.005125:0.003024:0.008376:0.003024:0.005125:0.008104:0.004188:0.005231:0.013138:0.009223:0.009782:0.009827:0.005231:0.005866:0.005125:0.010326:0.010311:0.003024:0.009827:0.004188:0.005231:0.004747:0.009903:0.009192:0.004551:0.005216:0.005125:0.009903:0.005216:0.005866:0.003024:0.007257:0.005020:0.014182:0.009903:0.009223:0.005125:0.009223:0.003024:0.008104:0.005231:0.008376:0.003024:0.005866:0.003024:0.005125:0.005866:0.005246:0.010326:0.004551:0.009827:0.004188
sufficient.:@0.076196:0.517512:0.144534:0.517512:0.144534:0.501730:0.076196:0.501730:0.005866:0.009192:0.004747:0.003681:0.003681:0.009782:0.003024:0.009827:0.009223:0.005125:0.004188
patient education, ideally by a rheumatology nurse, :@0.090483:0.531032:0.485151:0.531032:0.485151:0.515249:0.090483:0.515249:0.008950:0.010326:0.005125:0.003024:0.009827:0.009223:0.005125:0.005851:0.009827:0.010357:0.009192:0.009782:0.010326:0.005125:0.003024:0.009903:0.009223:0.004188:0.005851:0.003024:0.010357:0.009827:0.010326:0.003024:0.003024:0.008104:0.005866:0.010311:0.008104:0.005866:0.010326:0.005851:0.004551:0.009223:0.009827:0.009192:0.014182:0.010326:0.005125:0.009903:0.003024:0.009903:0.010175:0.008104:0.005836:0.009223:0.009192:0.004551:0.005866:0.009827:0.004188:0.004188
is paramount  to  ensure  successful outcomes.  shared :@0.076196:0.544552:0.485151:0.544552:0.485151:0.528769:0.076196:0.528769:0.003024:0.005866:0.007726:0.010311:0.010326:0.004551:0.010326:0.014182:0.009903:0.009192:0.009223:0.005125:0.004188:0.003523:0.005125:0.009903:0.004188:0.003523:0.009827:0.009223:0.005866:0.009192:0.004551:0.009827:0.004188:0.003523:0.005866:0.009192:0.009782:0.009782:0.009827:0.005866:0.005866:0.004747:0.009192:0.003024:0.007726:0.009903:0.009192:0.005125:0.009782:0.009903:0.014182:0.009827:0.005866:0.004188:0.004188:0.003523:0.007529:0.009223:0.010326:0.004551:0.009827:0.010357:0.004188
decision-making allows  patients to participate in their :@0.076196:0.558071:0.485151:0.558071:0.485151:0.542289:0.076196:0.542289:0.010357:0.009827:0.009782:0.003024:0.005866:0.003024:0.009903:0.009223:0.005020:0.014182:0.010326:0.007590:0.003024:0.009223:0.010175:0.006652:0.010326:0.003024:0.003024:0.009903:0.012564:0.005866:0.004188:0.002480:0.010311:0.010326:0.005125:0.003024:0.009827:0.009223:0.005125:0.005866:0.006652:0.005125:0.009903:0.006652:0.010311:0.010326:0.004551:0.005125:0.003024:0.009782:0.003024:0.010311:0.010326:0.005125:0.009827:0.006652:0.003024:0.009223:0.006652:0.005125:0.009223:0.009827:0.003024:0.004551:0.004188
treatment, thus considering patient’s values and prefer-:@0.076196:0.571591:0.480963:0.571591:0.480963:0.555809:0.076196:0.555809:0.005125:0.004551:0.009827:0.010326:0.005125:0.014182:0.009827:0.009223:0.005125:0.004188:0.003886:0.005125:0.009223:0.009192:0.005866:0.003901:0.009782:0.009903:0.009223:0.005866:0.003024:0.010357:0.009827:0.004551:0.003024:0.009223:0.010175:0.003901:0.010311:0.010326:0.005125:0.003024:0.009827:0.009223:0.005125:0.005307:0.005866:0.003901:0.008376:0.010326:0.003024:0.009192:0.009827:0.005866:0.003916:0.010326:0.009223:0.010357:0.003901:0.010311:0.004551:0.009827:0.004747:0.009827:0.004566:0.005020
ences over and above best scientific evidence.:@0.076196:0.585111:0.425733:0.585111:0.425733:0.569328:0.076196:0.569328:0.009827:0.009223:0.009782:0.009827:0.005866:0.004188:0.009903:0.008376:0.009827:0.004551:0.004188:0.010326:0.009223:0.010357:0.004188:0.010326:0.010311:0.009903:0.008376:0.009827:0.004188:0.010311:0.009827:0.005866:0.005125:0.004188:0.005866:0.009782:0.003024:0.009827:0.009223:0.005125:0.003024:0.003681:0.003681:0.009782:0.004188:0.009827:0.008376:0.003024:0.010357:0.009827:0.009223:0.009782:0.009827:0.004188
14:@0.425707:0.579746:0.435424:0.579746:0.435424:0.570593:0.425707:0.570593:0.004858:0.004858
Patients with inflammatory arthritis have an increased :@0.090476:0.598562:0.485113:0.598562:0.485113:0.582779:0.090476:0.582779:0.008950:0.010326:0.005125:0.003024:0.009827:0.009223:0.005125:0.005866:0.004309:0.012564:0.003024:0.005125:0.009223:0.004309:0.003024:0.009223:0.003666:0.003666:0.010326:0.014182:0.014182:0.010326:0.005125:0.009903:0.004551:0.008104:0.004309:0.010326:0.004551:0.005125:0.009223:0.004551:0.003024:0.005125:0.003024:0.005866:0.004309:0.009223:0.010326:0.008376:0.009827:0.004324:0.010326:0.009223:0.004309:0.003024:0.009223:0.009782:0.004551:0.009827:0.010326:0.005866:0.009827:0.010357:0.004188
risk of cardiovascular morbidity. Uncontrolled  severe :@0.076189:0.612082:0.485143:0.612082:0.485143:0.596299:0.076189:0.596299:0.004551:0.003024:0.005866:0.007590:0.008966:0.009903:0.004747:0.008966:0.009782:0.010326:0.004551:0.010357:0.003024:0.009903:0.008376:0.010326:0.005866:0.009782:0.009192:0.003024:0.010326:0.004551:0.008966:0.014182:0.009903:0.004551:0.010311:0.003024:0.010357:0.003024:0.005125:0.008104:0.004188:0.008966:0.009903:0.009223:0.009782:0.009903:0.009223:0.005125:0.004551:0.009903:0.003024:0.003024:0.009827:0.010357:0.004188:0.004762:0.005866:0.009827:0.008376:0.009827:0.004551:0.009827:0.004188
joint  inflammation,  extra-articular  disease,  physical  in:@0.076189:0.625601:0.475936:0.625601:0.475936:0.609819:0.076189:0.609819:0.003069:0.009903:0.003024:0.009223:0.005125:0.004188:0.003039:0.003024:0.009223:0.003666:0.003666:0.010326:0.014182:0.014182:0.010326:0.005125:0.003024:0.009903:0.009223:0.004188:0.004188:0.003039:0.009827:0.007257:0.005125:0.004551:0.010326:0.005020:0.010326:0.004551:0.005125:0.003024:0.009782:0.009192:0.003024:0.010326:0.004551:0.004188:0.003039:0.010357:0.003024:0.005866:0.009827:0.010326:0.005866:0.009827:0.004188:0.004188:0.003039:0.010311:0.009223:0.008104:0.005866:0.003024:0.009782:0.010326:0.003024:0.004188:0.003054:0.003024:0.009223
-:@0.475936:0.625601:0.480955:0.625601:0.480955:0.609819:0.475936:0.609819:0.005020
activity and corticosteroid use contribute to the risk of :@0.076189:0.639121:0.485143:0.639121:0.485143:0.623338:0.076189:0.623338:0.010326:0.009782:0.005125:0.003024:0.008376:0.003024:0.005125:0.008104:0.005685:0.010326:0.009223:0.010357:0.005685:0.009782:0.009903:0.004551:0.005125:0.003024:0.009782:0.009903:0.005866:0.005125:0.009827:0.004551:0.009903:0.003024:0.010357:0.005670:0.009192:0.005866:0.009827:0.005685:0.009782:0.009903:0.009223:0.005125:0.004551:0.003024:0.010311:0.009192:0.005125:0.009827:0.005670:0.005125:0.009903:0.005670:0.005125:0.009223:0.009827:0.005670:0.004551:0.003024:0.005866:0.007590:0.005685:0.009903:0.004747:0.004188
cardiovascular events. Controlling  disease activity has :@0.076189:0.652641:0.485134:0.652628:0.485134:0.636846:0.076189:0.636858:0.009782:0.010326:0.004551:0.010357:0.003024:0.009903:0.008376:0.010326:0.005866:0.009782:0.009192:0.003024:0.010326:0.004551:0.006607:0.009827:0.008376:0.009827:0.009223:0.005125:0.005866:0.004188:0.003665:0.012292:0.009903:0.009223:0.005125:0.004551:0.009903:0.003024:0.003024:0.003024:0.009223:0.010175:0.004188:0.002404:0.010357:0.003024:0.005866:0.009827:0.010326:0.005866:0.009827:0.006607:0.010326:0.009782:0.005125:0.003024:0.008376:0.003024:0.005125:0.008104:0.006607:0.009223:0.010326:0.005866:-0.005387
 :@0.244612:0.651053:0.246939:0.651053:0.246939:0.642285:0.244612:0.642285:0.002327
been shown to decrease cardiovascular risk, however :@0.076195:0.666148:0.485165:0.666148:0.485165:0.650365:0.076195:0.650365:0.010311:0.009827:0.009827:0.009223:0.005760:0.005866:0.009223:0.009903:0.012564:0.009223:0.005745:0.005125:0.009903:0.005760:0.010357:0.009827:0.009782:0.004551:0.009827:0.010326:0.005866:0.009827:0.005760:0.009782:0.010326:0.004551:0.010357:0.003024:0.009903:0.008376:0.010326:0.005866:0.009782:0.009192:0.003024:0.010326:0.004551:0.005760:0.004551:0.003024:0.005866:0.007590:0.004188:0.005760:0.009223:0.009903:0.012564:0.009827:0.008376:0.009827:0.004551:0.004188
traditional risk factors, including smoking, hypertension, :@0.076195:0.679668:0.485149:0.679668:0.485149:0.663885:0.076195:0.663885:0.005125:0.004551:0.010326:0.010357:0.003024:0.005125:0.003024:0.009903:0.009223:0.010326:0.003024:0.005140:0.004551:0.003024:0.005866:0.007590:0.005140:0.004747:0.010326:0.009782:0.005125:0.009903:0.004551:0.005866:0.004188:0.005125:0.003024:0.009223:0.009782:0.003024:0.009192:0.010357:0.003024:0.009223:0.010175:0.005140:0.005866:0.014182:0.009903:0.007590:0.003024:0.009223:0.010175:0.004188:0.005125:0.009223:0.008104:0.010311:0.009827:0.004551:0.005125:0.009827:0.009223:0.005866:0.003024:0.009903:0.009223:0.004188:0.004188
diabetes mellitus and dyslipidaemia, need to be man-:@0.076195:0.693187:0.480961:0.693187:0.480961:0.677405:0.076195:0.677405:0.010357:0.003024:0.010326:0.010311:0.009827:0.005125:0.009827:0.005866:0.005413:0.014182:0.009827:0.003024:0.003024:0.003024:0.005125:0.009192:0.005866:0.005413:0.010326:0.009223:0.010357:0.005397:0.010357:0.008104:0.005866:0.003024:0.003024:0.010311:0.003024:0.010357:0.010326:0.009827:0.014182:0.003024:0.010326:0.004188:0.005428:0.009223:0.009827:0.009827:0.010357:0.005397:0.005125:0.009903:0.005397:0.010311:0.009827:0.005397:0.014182:0.010326:0.009223:0.005020
aged accordingly.:@0.076195:0.706707:0.213506:0.706707:0.213506:0.690924:0.076195:0.690924:0.010326:0.010175:0.009827:0.010357:0.004188:0.010326:0.009782:0.009782:0.009903:0.004551:0.010357:0.003024:0.009223:0.010175:0.003024:0.008104:0.004188
Finally, management must involve a multidisciplinary :@0.090482:0.720227:0.485119:0.720227:0.485119:0.704444:0.090482:0.704444:0.007333:0.003024:0.009223:0.010326:0.003024:0.003024:0.008104:0.004188:0.005639:0.014182:0.010326:0.009223:0.010326:0.010175:0.009827:0.014182:0.009827:0.009223:0.005125:0.005624:0.014182:0.009192:0.005866:0.005125:0.005639:0.003024:0.009223:0.008376:0.009903:0.003024:0.008376:0.009827:0.005639:0.010326:0.005639:0.014182:0.009192:0.003024:0.005125:0.003024:0.010357:0.003024:0.005866:0.009782:0.003024:0.010311:0.003024:0.003024:0.009223:0.010326:0.004551:0.008104:0.004188
team which includes physiotherapy, occupational ther-:@0.076195:0.733746:0.480961:0.733746:0.480961:0.717964:0.076195:0.717964:0.005125:0.009827:0.010326:0.014182:0.003886:0.012564:0.009223:0.003024:0.009782:0.009223:0.003886:0.003024:0.009223:0.009782:0.003024:0.009192:0.010357:0.009827:0.005866:0.003886:0.010311:0.009223:0.008104:0.005866:0.003024:0.009903:0.005125:0.009223:0.009827:0.004551:0.010326:0.010311:0.008104:0.004188:0.003886:0.009903:0.009782:0.009782:0.009192:0.010311:0.010326:0.005125:0.003024:0.009903:0.009223:0.010326:0.003024:0.003886:0.005125:0.009223:0.009827:0.004566:0.005020
apy, podiatry and psychology.:@0.076195:0.747266:0.301876:0.747266:0.301876:0.731484:0.076195:0.731484:0.010326:0.010311:0.008104:0.004188:0.004188:0.010311:0.009903:0.010357:0.003024:0.010326:0.005125:0.004551:0.008104:0.004188:0.010326:0.009223:0.010357:0.004188:0.010311:0.005866:0.008104:0.009782:0.009223:0.009903:0.003024:0.009903:0.010175:0.008104:0.004188
DruG tHerAPies in inflAmmAtOry ArtHritis:@0.076190:0.779508:0.480877:0.779508:0.480877:0.759343:0.076190:0.759343:0.012935:0.010718:0.011826:0.015522:0.005174:0.007761:0.012566:0.009609:0.010718:0.013674:0.010348:0.005174:0.009609:0.009609:0.005174:0.005174:0.013674:0.005174:0.005174:0.013674:0.008870:0.008131:0.013674:0.016631:0.016631:0.013674:0.007761:0.015522:0.010718:0.011457:0.005174:0.013674:0.010718:0.007761:0.012566:0.010718:0.005174:0.007761:0.005174:0.009609
Nonsteroidal anti-inflammatory drugs:@0.076190:0.804176:0.378235:0.804176:0.378235:0.785845:0.076190:0.785845:0.012431:0.010751:0.010079:0.007392:0.005040:0.010751:0.005376:0.010751:0.004032:0.011087:0.011087:0.004032:0.004704:0.011087:0.010079:0.005040:0.004032:0.007056:0.004032:0.010079:0.004368:0.004368:0.011087:0.015791:0.015791:0.011087:0.005040:0.010751:0.005376:0.009743:0.004704:0.011087:0.005376:0.010079:0.011087:0.007392
In rheumatoid arthritis, NsAIDs should be used at the low-:@0.076190:0.819865:0.480912:0.819865:0.480912:0.804082:0.076190:0.804082:0.003266:0.009071:0.003901:0.004400:0.009071:0.009676:0.009041:0.014030:0.010175:0.004974:0.009752:0.002873:0.010205:0.003901:0.010175:0.004400:0.004974:0.009071:0.004400:0.002873:0.004974:0.002873:0.005715:0.004037:0.003901:0.011037:0.007378:0.011037:0.003266:0.011097:0.005715:0.003901:0.005715:0.009071:0.009752:0.009041:0.002873:0.010205:0.003901:0.010160:0.009676:0.003901:0.009041:0.005715:0.009676:0.010205:0.003901:0.010175:0.004974:0.003901:0.004974:0.009071:0.009676:0.003901:0.002873:0.009752:0.012413:0.005020
est  effective  dose  and  should  be  discontinued  once :@0.076190:0.833384:0.485115:0.833384:0.485115:0.817602:0.076190:0.817602:0.009676:0.005715:0.004974:0.004188:0.004067:0.009676:0.004596:0.004596:0.009676:0.009631:0.004974:0.002873:0.008225:0.009676:0.004188:0.004067:0.010205:0.009752:0.005715:0.009676:0.004188:0.004067:0.010175:0.009071:0.010205:0.004188:0.004067:0.005715:0.009071:0.009752:0.009041:0.002873:0.010205:0.004188:0.004067:0.010160:0.009676:0.004188:0.004067:0.010205:0.002873:0.005715:0.009631:0.009752:0.009071:0.004974:0.002873:0.009071:0.009041:0.009676:0.010205:0.004188:0.004067:0.009752:0.009071:0.009631:0.009827:0.004188
disease activity is controlled. Conversely, in spA, NsAIDs :@0.076190:0.847412:0.485145:0.847412:0.485145:0.831630:0.076190:0.831630:0.010205:0.002873:0.005715:0.009676:0.010175:0.005715:0.009676:0.005261:0.010175:0.009631:0.004974:0.002873:0.008225:0.002873:0.004974:0.007953:0.005261:0.002873:0.005715:0.005261:0.009631:0.009752:0.009071:0.004974:0.004400:0.009752:0.002873:0.002873:0.009676:0.010205:0.004037:0.005261:0.012141:0.009752:0.009071:0.008225:0.009676:0.004400:0.005715:0.009676:0.002873:0.007953:0.004037:0.005261:0.002873:0.009071:0.005261:0.007378:0.008799:0.011037:0.004037:0.005261:0.011037:0.007378:0.011037:0.003266:0.011097:0.005866:0.004188
are considered disease-modifying and should be used at :@0.076190:0.861440:0.485175:0.861440:0.485175:0.845657:0.076190:0.845657:0.010175:0.004400:0.009676:0.003311:0.009631:0.009752:0.009071:0.005715:0.002873:0.010205:0.009676:0.004400:0.009676:0.010205:0.003311:0.010205:0.002873:0.005715:0.009676:0.010175:0.005715:0.009676:0.004868:0.014030:0.009752:0.010205:0.002873:0.004596:0.007953:0.002873:0.009071:0.010024:0.003311:0.010175:0.009071:0.010205:0.003311:0.005715:0.009071:0.009752:0.009041:0.002873:0.010205:0.003311:0.010160:0.009676:0.003311:0.009041:0.005715:0.009676:0.010205:0.003311:0.010175:0.005125:0.004188
maximal tolerable doses. still, one must observe caution :@0.076190:0.875468:0.485175:0.875468:0.485175:0.859685:0.076190:0.859685:0.014030:0.010175:0.007106:0.002873:0.014030:0.010175:0.002873:0.004762:0.004974:0.009752:0.002873:0.009676:0.004400:0.010175:0.010160:0.002873:0.009676:0.004762:0.010205:0.009752:0.005715:0.009676:0.005715:0.004037:0.004762:0.007378:0.004974:0.002873:0.002873:0.002873:0.004037:0.004762:0.009752:0.009071:0.009676:0.004762:0.014030:0.009041:0.005715:0.004974:0.004762:0.009752:0.010160:0.005715:0.009676:0.004400:0.008225:0.009676:0.004762:0.009631:0.010175:0.009041:0.004974:0.002873:0.009752:0.009223:0.004188
when prescribing NsAIDs, particularly in the elderly and :@0.076190:0.889495:0.485160:0.889495:0.485160:0.873713:0.076190:0.873713:0.012413:0.009071:0.009676:0.009071:0.005639:0.010160:0.004400:0.009676:0.005715:0.009631:0.004400:0.002873:0.010160:0.002873:0.009071:0.010024:0.005655:0.011037:0.007378:0.011037:0.003266:0.011097:0.005715:0.004037:0.005639:0.010160:0.010175:0.004400:0.004974:0.002873:0.009631:0.009041:0.002873:0.010175:0.004400:0.002873:0.007953:0.005655:0.002873:0.009071:0.005655:0.004974:0.009071:0.009676:0.005655:0.009676:0.002873:0.010205:0.009676:0.004400:0.002873:0.007953:0.005655:0.010175:0.009071:0.010357:0.004188
patients with renal or cardiovascular disease. Use pro-:@0.076190:0.903523:0.480927:0.903523:0.480927:0.887740:0.076190:0.887740:0.010160:0.010175:0.004974:0.002873:0.009676:0.009071:0.004974:0.005715:0.006804:0.012413:0.002873:0.004974:0.009071:0.006804:0.004400:0.009676:0.009071:0.010175:0.002873:0.006804:0.009752:0.004400:0.006804:0.009631:0.010175:0.004400:0.010205:0.002873:0.009752:0.008225:0.010175:0.005715:0.009631:0.009041:0.002873:0.010175:0.004400:0.006804:0.010205:0.002873:0.005715:0.009676:0.010175:0.005715:0.009676:0.004037:0.006804:0.009752:0.005715:0.009676:0.006804:0.010160:0.004400:0.009752:0.005020
ton pump inhibitors or COX-2 selective agents for gastric :@0.076190:0.917551:0.485145:0.917551:0.485145:0.901768:0.076190:0.901768:0.004974:0.009752:0.009071:0.004339:0.010160:0.009041:0.014030:0.010160:0.004339:0.002873:0.009071:0.009071:0.002873:0.010160:0.002873:0.004974:0.009752:0.004400:0.005715:0.004339:0.009752:0.004400:0.004339:0.012141:0.012987:0.009056:0.004868:0.008225:0.004339:0.005715:0.009676:0.002873:0.009676:0.009631:0.004974:0.002873:0.008225:0.009676:0.004339:0.010175:0.010024:0.009676:0.009071:0.004974:0.005715:0.004339:0.004596:0.009752:0.004400:0.004369:0.010024:0.010175:0.005715:0.004974:0.004400:0.002873:0.009782:0.004188
protection. Worsening hypertension, renal injury and liver :@0.076190:0.931451:0.485191:0.931451:0.485191:0.915669:0.076190:0.915669:0.010160:0.004400:0.009752:0.004974:0.009676:0.009631:0.004974:0.002873:0.009752:0.009071:0.004037:0.004007:0.014363:0.009752:0.004400:0.005715:0.009676:0.009071:0.002873:0.009071:0.010024:0.004007:0.009071:0.007953:0.010160:0.009676:0.004400:0.004974:0.009676:0.009071:0.005715:0.002873:0.009752:0.009071:0.004037:0.004007:0.004400:0.009676:0.009071:0.010175:0.002873:0.004007:0.002873:0.009071:0.002918:0.009041:0.004400:0.007953:0.004007:0.010175:0.009071:0.010205:0.004007:0.002873:0.002873:0.008225:0.009676:0.004551:0.004188
dysfunction can complicate chronic NsAID use.:@0.076190:0.945352:0.418773:0.945352:0.418773:0.929570:0.076190:0.929570:0.010205:0.007953:0.005715:0.004596:0.009041:0.009071:0.009631:0.004974:0.002873:0.009752:0.009071:0.004037:0.009631:0.010175:0.009071:0.004037:0.009631:0.009752:0.014030:0.010160:0.002873:0.002873:0.009631:0.010175:0.004974:0.009676:0.004037:0.009631:0.009071:0.004400:0.009752:0.009071:0.002873:0.009631:0.004037:0.011037:0.007378:0.011037:0.003266:0.011097:0.004037:0.009041:0.005715:0.009676:0.004188
Glucocorticoids :@0.519047:0.086287:0.653439:0.086287:0.653439:0.067956:0.519047:0.067956:0.014111:0.004032:0.010079:0.010751:0.010751:0.010751:0.010751:0.005376:0.005040:0.004032:0.010751:0.010751:0.004032:0.011087:0.007392:0.004704
Low-dose oral prednisone (≤7.5 mg/day) is appropriate :@0.519047:0.102315:0.927987:0.102315:0.927987:0.086533:0.519047:0.086533:0.006985:0.009903:0.012564:0.005020:0.010357:0.009903:0.005866:0.009827:0.004460:0.009903:0.004551:0.010326:0.003024:0.004460:0.010311:0.004551:0.009827:0.010357:0.009223:0.003024:0.005866:0.009903:0.009223:0.009827:0.004460:0.005579:0.008300:0.008376:0.004188:0.008376:0.004475:0.014182:0.010175:0.006607:0.010357:0.010326:0.008104:0.005579:0.004475:0.003024:0.005866:0.004475:0.010326:0.010311:0.010311:0.004551:0.009903:0.010311:0.004551:0.003024:0.010326:0.005125:0.009827:0.004188
in early arthritis to potentiate the effect of DMARDs, or :@0.519047:0.116170:0.927987:0.116170:0.927987:0.100387:0.519047:0.100387:0.003024:0.009223:0.005428:0.009827:0.010326:0.004551:0.003024:0.008104:0.005443:0.010326:0.004551:0.005125:0.009223:0.004551:0.003024:0.005125:0.003024:0.005866:0.005428:0.005125:0.009903:0.005428:0.010311:0.009903:0.005125:0.009827:0.009223:0.005125:0.003024:0.010326:0.005125:0.009827:0.005428:0.005125:0.009223:0.009827:0.005428:0.009827:0.004747:0.004747:0.009827:0.009782:0.005125:0.005428:0.009903:0.004747:0.005428:0.011249:0.013894:0.011188:0.009177:0.011249:0.005866:0.004188:0.005428:0.009903:0.004551:0.004188
in established RA as “bridging therapy” upon initiation :@0.519047:0.130024:0.928002:0.130024:0.928002:0.114242:0.519047:0.114242:0.003024:0.009223:0.005760:0.009827:0.005866:0.005125:0.010326:0.010311:0.003024:0.003024:0.005866:0.009223:0.009827:0.010357:0.005760:0.009177:0.011188:0.005760:0.010326:0.005866:0.005760:0.007590:0.010311:0.004551:0.003024:0.010357:0.010175:0.003024:0.009223:0.010175:0.005760:0.005125:0.009223:0.009827:0.004551:0.010326:0.010311:0.008104:0.007318:0.005760:0.009192:0.010311:0.009903:0.009223:0.005760:0.003024:0.009223:0.003024:0.005125:0.003024:0.010326:0.005125:0.003024:0.009903:0.009223:0.004188
of  DMARDs.  There  is no  role  for  glucocorticoids  (GCs) :@0.519047:0.143879:0.927972:0.143879:0.927972:0.128096:0.519047:0.128096:0.009903:0.004747:0.004188:0.002434:0.011249:0.013894:0.011188:0.009177:0.011249:0.005866:0.004188:0.004188:0.002434:0.006441:0.009223:0.009827:0.004551:0.009827:0.004188:0.002434:0.003024:0.005866:0.006637:0.009223:0.009903:0.004188:0.002434:0.004551:0.009903:0.003024:0.009827:0.004188:0.002434:0.004747:0.009903:0.004551:0.004188:0.002434:0.010175:0.003024:0.009192:0.009782:0.009903:0.009782:0.009903:0.004551:0.005125:0.003024:0.009782:0.009903:0.003024:0.010357:0.005866:0.004188:0.002434:0.005579:0.013184:0.012292:0.005866:0.005579:0.004188
as monotherapy  for  the  treatment  of  RA,  and doses :@0.519047:0.157734:0.927987:0.157734:0.927987:0.141951:0.519047:0.141951:0.010326:0.005866:0.007544:0.014182:0.009903:0.009223:0.009903:0.005125:0.009223:0.009827:0.004551:0.010326:0.010311:0.008104:0.004188:0.003341:0.004747:0.009903:0.004551:0.004188:0.003341:0.005125:0.009223:0.009827:0.004188:0.003341:0.005125:0.004551:0.009827:0.010326:0.005125:0.014182:0.009827:0.009223:0.005125:0.004188:0.003341:0.009903:0.004747:0.004188:0.003341:0.009177:0.011188:0.004188:0.004188:0.003341:0.010326:0.009223:0.010357:0.007544:0.010357:0.009903:0.005866:0.009827:0.005866:0.004188
>10 mg/day should never be used to control early ar-:@0.519047:0.171588:0.923799:0.171588:0.923799:0.155805:0.519047:0.155805:0.009162:0.008376:0.008376:0.005791:0.014182:0.010175:0.006607:0.010357:0.010326:0.008104:0.005791:0.005866:0.009223:0.009903:0.009192:0.003024:0.010357:0.005791:0.009223:0.009827:0.008376:0.009827:0.004551:0.005775:0.010311:0.009827:0.005791:0.009192:0.005866:0.009827:0.010357:0.005791:0.005125:0.009903:0.005775:0.009782:0.009903:0.009223:0.005125:0.004551:0.009903:0.003024:0.005775:0.009827:0.010326:0.004551:0.003024:0.008104:0.005791:0.010326:0.004551:0.005020
ticular  disease  or  flares.  Intramuscular  glucocorticoids :@0.519047:0.185443:0.927987:0.185443:0.927987:0.169660:0.519047:0.169660:0.005125:0.003024:0.009782:0.009192:0.003024:0.010326:0.004551:0.004188:0.003009:0.010357:0.003024:0.005866:0.009827:0.010326:0.005866:0.009827:0.004188:0.003009:0.009903:0.004551:0.004188:0.002994:0.003666:0.003666:0.010326:0.004551:0.009827:0.005866:0.004188:0.004188:0.002994:0.003417:0.009223:0.005125:0.004551:0.010326:0.014182:0.009192:0.005866:0.009782:0.009192:0.003024:0.010326:0.004551:0.004188:0.002994:0.010175:0.003024:0.009192:0.009782:0.009903:0.009782:0.009903:0.004551:0.005125:0.003024:0.009782:0.009903:0.003024:0.010357:0.005866:0.004188
(80-120 mg Depo-Medrol) may be used as an alterna-:@0.519047:0.199297:0.923799:0.199297:0.923799:0.183515:0.519047:0.183515:0.005579:0.008376:0.008376:0.005020:0.008376:0.008376:0.008376:0.005428:0.014182:0.010175:0.005413:0.011249:0.009827:0.010311:0.009903:0.005020:0.013894:0.009827:0.010357:0.004551:0.009903:0.003024:0.005579:0.005413:0.014182:0.010326:0.008104:0.005413:0.010311:0.009827:0.005413:0.009192:0.005866:0.009827:0.010357:0.005413:0.010326:0.005866:0.005413:0.010326:0.009223:0.005413:0.010326:0.003024:0.005125:0.009827:0.004551:0.009223:0.010326:0.005020
tive to oral prednisone. Intra-articular steroids are useful :@0.519047:0.213152:0.927987:0.213152:0.927987:0.197369:0.519047:0.197369:0.005125:0.003024:0.008376:0.009827:0.004385:0.005125:0.009903:0.004369:0.009903:0.004551:0.010326:0.003024:0.004385:0.010311:0.004551:0.009827:0.010357:0.009223:0.003024:0.005866:0.009903:0.009223:0.009827:0.004188:0.004369:0.003417:0.009223:0.005125:0.004551:0.010326:0.005020:0.010326:0.004551:0.005125:0.003024:0.009782:0.009192:0.003024:0.010326:0.004551:0.004369:0.005866:0.005125:0.009827:0.004551:0.009903:0.003024:0.010357:0.005866:0.004385:0.010326:0.004551:0.009827:0.004369:0.009192:0.005866:0.009827:0.004747:0.009192:0.003024:0.004188
to  control  joint  flares.  Glucocoticoids,  in  moderate  to :@0.519047:0.227006:0.927972:0.227006:0.927972:0.211224:0.519047:0.211224:0.005125:0.009903:0.004188:0.002721:0.009782:0.009903:0.009223:0.005110:0.004551:0.009903:0.003024:0.004188:0.002721:0.003069:0.009903:0.003024:0.009223:0.005125:0.004188:0.002721:0.003666:0.003666:0.010326:0.004551:0.009827:0.005866:0.004188:0.004188:0.002721:0.013184:0.003024:0.009192:0.009782:0.009903:0.009782:0.009903:0.005125:0.003024:0.009782:0.009903:0.003024:0.010357:0.005866:0.004188:0.004188:0.002721:0.003024:0.009223:0.004188:0.002721:0.014182:0.009903:0.010357:0.009827:0.004551:0.010326:0.005125:0.009827:0.004188:0.002721:0.005125:0.009903:0.004188
high doses, are frequently used to control extra-articular :@0.519047:0.240861:0.928002:0.240861:0.928002:0.225078:0.519047:0.225078:0.009223:0.003024:0.010175:0.009223:0.003523:0.010357:0.009903:0.005866:0.009827:0.005866:0.004188:0.003538:0.010326:0.004551:0.009827:0.003523:0.004747:0.004551:0.009827:0.010311:0.009192:0.009827:0.009223:0.005125:0.003024:0.008104:0.003523:0.009192:0.005866:0.009827:0.010357:0.003538:0.005125:0.009903:0.003523:0.009782:0.009903:0.009223:0.005125:0.004551:0.009903:0.003024:0.003523:0.009827:0.007257:0.005125:0.004551:0.010326:0.005020:0.010326:0.004551:0.005125:0.003024:0.009782:0.009192:0.003024:0.010326:0.004551:0.004188
manifestations of the disease. There is no role for ster-:@0.519047:0.254715:0.923799:0.254715:0.923799:0.238933:0.519047:0.238933:0.014182:0.010326:0.009223:0.003024:0.004747:0.009827:0.005866:0.005125:0.010326:0.005125:0.003024:0.009903:0.009223:0.005866:0.006229:0.009903:0.004747:0.006229:0.005125:0.009223:0.009827:0.006229:0.010357:0.003024:0.005866:0.009827:0.010326:0.005866:0.009827:0.004188:0.006229:0.006441:0.009223:0.009827:0.004551:0.009827:0.006229:0.003024:0.005866:0.006244:0.009223:0.009903:0.006229:0.004551:0.009903:0.003024:0.009827:0.006229:0.004747:0.009903:0.004551:0.006229:0.005866:0.005125:0.009827:0.004551:0.005020
oids in As or psA, and their withdrawal can potentially :@0.519047:0.268570:0.928002:0.268570:0.928002:0.252787:0.519047:0.252787:0.009903:0.003024:0.010357:0.005866:0.005473:0.003024:0.009223:0.005473:0.011188:0.007529:0.005473:0.009903:0.004551:0.005473:0.008950:0.007529:0.011188:0.004188:0.005473:0.010326:0.009223:0.010357:0.005473:0.005125:0.009223:0.009827:0.003024:0.004551:0.005473:0.012564:0.003024:0.005125:0.009223:0.010357:0.004551:0.010326:0.012564:0.010326:0.003024:0.005473:0.009782:0.010326:0.009223:0.005473:0.010311:0.009903:0.005125:0.009827:0.009223:0.005125:0.003024:0.010326:0.003024:0.003024:0.008104:0.004188
induce a flare in psoriasis.:@0.519047:0.282424:0.704739:0.282424:0.704739:0.266642:0.519047:0.266642:0.003024:0.009223:0.010357:0.009192:0.009782:0.009827:0.004188:0.010326:0.004188:0.003666:0.003666:0.010326:0.004551:0.009827:0.004188:0.003024:0.009223:0.004188:0.010311:0.005866:0.009903:0.004551:0.003024:0.010326:0.005866:0.003024:0.005866:0.004188
12:@0.704735:0.277148:0.714451:0.277148:0.714451:0.267994:0.704735:0.267994:0.004858:0.004858
Conventional synthetic DmArDs :@0.519047:0.313374:0.783462:0.313374:0.783462:0.295042:0.519047:0.295042:0.013103:0.010751:0.010079:0.009407:0.010751:0.010079:0.005040:0.004032:0.010751:0.010079:0.011087:0.004032:0.004704:0.007392:0.009743:0.010079:0.005040:0.010079:0.010751:0.005040:0.004032:0.010751:0.004704:0.011759:0.015119:0.012431:0.009743:0.011759:0.007392:0.004704
Disease-modifying anti-rheumatic drugs (DMARDs) are :@0.519047:0.329402:0.928002:0.329402:0.928002:0.313619:0.519047:0.313619:0.011249:0.003024:0.005866:0.009827:0.010326:0.005866:0.009827:0.005020:0.014182:0.009903:0.010357:0.003024:0.004747:0.008104:0.003024:0.009223:0.010175:0.006123:0.010326:0.009223:0.005125:0.003024:0.005020:0.004551:0.009223:0.009827:0.009192:0.014182:0.010326:0.005125:0.003024:0.009782:0.006108:0.010357:0.004551:0.009192:0.010175:0.005866:0.006108:0.005579:0.011249:0.013894:0.011188:0.009177:0.011249:0.005866:0.005579:0.006108:0.010326:0.004551:0.009827:0.004188
agents that can reduce or prevent joint damage and :@0.519047:0.343257:0.927972:0.343257:0.927972:0.327474:0.519047:0.327474:0.010326:0.010175:0.009827:0.009223:0.005125:0.005866:0.005549:0.005125:0.009223:0.010326:0.005125:0.005549:0.009782:0.010326:0.009223:0.005549:0.004551:0.009827:0.010357:0.009192:0.009782:0.009827:0.005549:0.009903:0.004551:0.005549:0.010311:0.004551:0.009827:0.008376:0.009827:0.009223:0.005125:0.005549:0.003069:0.009903:0.003024:0.009223:0.005125:0.005549:0.010357:0.010326:0.014182:0.010326:0.010175:0.009827:0.005549:0.010326:0.009223:0.010357:0.004188
preserve joint function. Conventional synthetic DMARDs :@0.519047:0.357111:0.928002:0.357111:0.928002:0.341328:0.519047:0.341328:0.010311:0.004551:0.009827:0.005866:0.009827:0.004551:0.008376:0.009827:0.003901:0.003069:0.009903:0.003024:0.009223:0.005125:0.003901:0.004747:0.009192:0.009223:0.009782:0.005125:0.003024:0.009903:0.009223:0.004188:0.003886:0.012292:0.009903:0.009223:0.008376:0.009827:0.009223:0.005125:0.003024:0.009903:0.009223:0.010326:0.003024:0.003901:0.005866:0.008104:0.009223:0.005125:0.009223:0.009827:0.005125:0.003024:0.009782:0.003901:0.011249:0.013894:0.011188:0.009177:0.011249:0.005866:0.004188
are listed below and summarised in Table 6.:@0.519047:0.370966:0.837938:0.370966:0.837938:0.355183:0.519047:0.355183:0.010326:0.004551:0.009827:0.004188:0.003024:0.003024:0.005866:0.005125:0.009827:0.010357:0.004188:0.010311:0.009827:0.003024:0.009903:0.012564:0.004188:0.010326:0.009223:0.010357:0.004188:0.005866:0.009192:0.014182:0.014182:0.010326:0.004551:0.003024:0.005866:0.009827:0.010357:0.004188:0.003024:0.009223:0.004188:0.006441:0.010326:0.010311:0.003024:0.009827:0.004188:0.008376:0.004188
Methotrexate:@0.533335:0.384820:0.633347:0.384820:0.633347:0.369038:0.533335:0.369038:0.013894:0.009827:0.005125:0.009223:0.009903:0.005125:0.004551:0.009827:0.007257:0.010326:0.005125:0.009827
 (MTX) is the drug of choice in RA due to :@0.633332:0.384820:0.927987:0.384820:0.927987:0.369038:0.633332:0.369038:0.003931:0.005579:0.013894:0.006441:0.009207:0.005579:0.003931:0.003024:0.005866:0.003931:0.005125:0.009223:0.009827:0.003916:0.010357:0.004551:0.009192:0.010175:0.003916:0.009903:0.004747:0.003916:0.009782:0.009223:0.009903:0.003024:0.009782:0.009827:0.003916:0.003024:0.009223:0.003931:0.009177:0.011188:0.003916:0.010357:0.009192:0.009827:0.003916:0.005125:0.009903:0.004188
its excellent efficacy and safety profile. It is also widely :@0.519047:0.398675:0.927972:0.398675:0.927972:0.382892:0.519047:0.382892:0.003024:0.005125:0.005866:0.005261:0.009827:0.007257:0.009782:0.009827:0.003024:0.003024:0.009827:0.009223:0.005125:0.005261:0.009827:0.004747:0.003681:0.003681:0.009782:0.010326:0.009782:0.008104:0.005261:0.010326:0.009223:0.010357:0.005261:0.005866:0.010326:0.004747:0.009827:0.005125:0.008104:0.005261:0.010311:0.004551:0.009903:0.003681:0.003681:0.003024:0.009827:0.004188:0.005261:0.003417:0.005125:0.005261:0.003024:0.005866:0.005261:0.010326:0.003024:0.005866:0.009903:0.005261:0.012564:0.003024:0.010357:0.009827:0.003024:0.008104:0.004188
used in psA, despite a lack of evidence to support its :@0.519047:0.412529:0.927987:0.412529:0.927987:0.396747:0.519047:0.396747:0.009192:0.005866:0.009827:0.010357:0.006078:0.003024:0.009223:0.006093:0.008950:0.007529:0.011188:0.004188:0.006078:0.010357:0.009827:0.005866:0.010311:0.003024:0.005125:0.009827:0.006093:0.010326:0.006078:0.003024:0.010326:0.009782:0.007590:0.006093:0.009903:0.004747:0.006078:0.009827:0.008376:0.003024:0.010357:0.009827:0.009223:0.009782:0.009827:0.006078:0.005125:0.009903:0.006078:0.005866:0.009192:0.010311:0.010311:0.009903:0.004551:0.005125:0.006078:0.003024:0.005125:0.005866:0.004188
use. There is no role for MTX in other forms of spA. :@0.519047:0.426384:0.878941:0.426384:0.878941:0.410601:0.519047:0.410601:0.009192:0.005866:0.009827:0.004188:0.004188:0.006441:0.009223:0.009827:0.004551:0.009827:0.004188:0.003024:0.005866:0.004188:0.009223:0.009903:0.004188:0.004551:0.009903:0.003024:0.009827:0.004188:0.004747:0.009903:0.004551:0.004188:0.013894:0.006441:0.009207:0.004188:0.003024:0.009223:0.004188:0.009903:0.005125:0.009223:0.009827:0.004551:0.004188:0.004747:0.009903:0.004551:0.014182:0.005866:0.004188:0.009903:0.004747:0.004188:0.007529:0.008950:0.011188:0.004188:0.004188
Antimalarials:@0.533335:0.440238:0.626543:0.440238:0.626543:0.424456:0.533335:0.424456:0.011188:0.009223:0.005125:0.003024:0.014182:0.010326:0.003024:0.010326:0.004551:0.003024:0.010326:0.003024:0.005866
 (chloroquine or hydroxychloroquine) are :@0.626543:0.440238:0.927987:0.440238:0.927987:0.424456:0.626543:0.424456:0.003387:0.005579:0.009782:0.009223:0.003024:0.009903:0.004551:0.009903:0.010311:0.009192:0.003024:0.009223:0.009827:0.003372:0.009903:0.004551:0.003387:0.009223:0.008104:0.010357:0.004551:0.009903:0.007257:0.008104:0.009782:0.009223:0.003024:0.009903:0.004551:0.009903:0.010311:0.009192:0.003024:0.009223:0.009827:0.005579:0.003372:0.010326:0.004551:0.009827:0.004188
frequently prescribed for lupus arthritis. In RA, they are :@0.519047:0.454093:0.927987:0.454093:0.927987:0.438310:0.519047:0.438310:0.004747:0.004551:0.009827:0.010311:0.009192:0.009827:0.009223:0.005125:0.003024:0.008104:0.005806:0.010311:0.004551:0.009827:0.005866:0.009782:0.004551:0.003024:0.010311:0.009827:0.010357:0.005806:0.004747:0.009903:0.004551:0.005806:0.003024:0.009192:0.010311:0.009192:0.005866:0.005806:0.010326:0.004551:0.005125:0.009223:0.004551:0.003024:0.005125:0.003024:0.005866:0.004188:0.005806:0.003417:0.009223:0.005806:0.009177:0.011188:0.004188:0.005806:0.005125:0.009223:0.009827:0.008104:0.005806:0.010326:0.004551:0.009827:0.004188
used as add-on therapy, when MTX alone is insufficient. :@0.519047:0.467947:0.928017:0.467947:0.928017:0.452165:0.519047:0.452165:0.009192:0.005866:0.009827:0.010357:0.004294:0.010326:0.005866:0.004294:0.010326:0.010357:0.010357:0.005020:0.009903:0.009223:0.004294:0.005125:0.009223:0.009827:0.004551:0.010326:0.010311:0.008104:0.004188:0.004294:0.012564:0.009223:0.009827:0.009223:0.004294:0.013894:0.006441:0.009207:0.004294:0.010326:0.003024:0.009903:0.009223:0.009827:0.004294:0.003024:0.005866:0.004294:0.003024:0.009223:0.005866:0.009192:0.004747:0.003681:0.003681:0.009782:0.003024:0.009827:0.009223:0.005125:0.004188:0.004188
There is no role for antimalarials in the treatment of spAs.:@0.519047:0.481802:0.923814:0.481802:0.923814:0.466019:0.519047:0.466019:0.006441:0.009223:0.009827:0.004551:0.009827:0.003583:0.003024:0.005866:0.003598:0.009223:0.009903:0.003583:0.004551:0.009903:0.003024:0.009827:0.003583:0.004747:0.009903:0.004551:0.003583:0.010326:0.009223:0.005125:0.003024:0.014182:0.010326:0.003024:0.010326:0.004551:0.003024:0.010326:0.003024:0.005866:0.003613:0.003024:0.009223:0.003598:0.005125:0.009223:0.009827:0.003583:0.005125:0.004551:0.009827:0.010326:0.005125:0.014182:0.009827:0.009223:0.005125:0.003583:0.009903:0.004747:0.003613:0.007529:0.008950:0.011188:0.005866:0.004188
Sulphasalazine:@0.533335:0.495656:0.640982:0.495656:0.640982:0.479874:0.533335:0.479874:0.007529:0.009192:0.003024:0.010311:0.009223:0.010326:0.005866:0.010326:0.003024:0.010326:0.006426:0.003024:0.009223:0.009827
 (ssZ) is effective as monotherapy in RA :@0.640997:0.495656:0.928017:0.495656:0.928017:0.479874:0.640997:0.479874:0.003674:0.005579:0.007529:0.007529:0.007257:0.005579:0.003674:0.003024:0.005866:0.003674:0.009827:0.004747:0.004747:0.009827:0.009782:0.005125:0.003024:0.008376:0.009827:0.003674:0.010326:0.005866:0.003674:0.014182:0.009903:0.009223:0.009903:0.005125:0.009223:0.009827:0.004551:0.010326:0.010311:0.008104:0.003659:0.003024:0.009223:0.003674:0.009177:0.011188:0.004188
when MTX is contra-indicated or as part of combination :@0.519062:0.509511:0.928002:0.509511:0.928002:0.493728:0.519062:0.493728:0.012564:0.009223:0.009827:0.009223:0.003855:0.013894:0.006441:0.009207:0.003855:0.003024:0.005866:0.003870:0.009782:0.009903:0.009223:0.005125:0.004551:0.010326:0.005020:0.003024:0.009223:0.010357:0.003024:0.009782:0.010326:0.005125:0.009827:0.010357:0.003855:0.009903:0.004551:0.003855:0.010326:0.005866:0.003870:0.010311:0.010326:0.004551:0.005125:0.003855:0.009903:0.004747:0.003855:0.009782:0.009903:0.014182:0.010311:0.003024:0.009223:0.010326:0.005125:0.003024:0.009903:0.009223:0.004188
DMARD therapy. It is also useful for treating peripheral :@0.519062:0.523366:0.928017:0.523366:0.928017:0.507583:0.519062:0.507583:0.011249:0.013894:0.011188:0.009177:0.011249:0.005806:0.005125:0.009223:0.009827:0.004551:0.010326:0.010311:0.008104:0.004188:0.005791:0.003417:0.005125:0.005806:0.003024:0.005866:0.005806:0.010326:0.003024:0.005866:0.009903:0.005806:0.009192:0.005866:0.009827:0.004747:0.009192:0.003024:0.005806:0.004747:0.009903:0.004551:0.005791:0.005125:0.004551:0.009827:0.010326:0.005125:0.003024:0.009223:0.010175:0.005791:0.010311:0.009827:0.004551:0.003024:0.010311:0.009223:0.009827:0.004551:0.010326:0.003024:0.004188
joint involvement in spAs. :@0.519062:0.537220:0.706236:0.537220:0.706236:0.521437:0.519062:0.521437:0.003069:0.009903:0.003024:0.009223:0.005125:0.004188:0.003024:0.009223:0.008376:0.009903:0.003024:0.008376:0.009827:0.014182:0.009827:0.009223:0.005125:0.004188:0.003024:0.009223:0.004188:0.007529:0.008950:0.011188:0.005866:0.004188:0.004188
Leflunomide:@0.533350:0.551075:0.623202:0.551075:0.623202:0.535292:0.533350:0.535292:0.006985:0.009827:0.003666:0.003666:0.009192:0.009223:0.009903:0.014182:0.003024:0.010357:0.009827
 may be prescribed as monotherapy or :@0.623187:0.551075:0.928032:0.551075:0.928032:0.535292:0.623187:0.535292:0.006365:0.014182:0.010326:0.008104:0.006365:0.010311:0.009827:0.006365:0.010311:0.004551:0.009827:0.005866:0.009782:0.004551:0.003024:0.010311:0.009827:0.010357:0.006365:0.010326:0.005866:0.006365:0.014182:0.009903:0.009223:0.009903:0.005125:0.009223:0.009827:0.004551:0.010326:0.010311:0.008104:0.006350:0.009903:0.004551:0.004188
co-prescribed with MTX in the treatment of RA and psA.:@0.519062:0.564929:0.923829:0.564929:0.923829:0.549147:0.519062:0.549147:0.009782:0.009903:0.005020:0.010311:0.004551:0.009827:0.005866:0.009782:0.004551:0.003024:0.010311:0.009827:0.010357:0.003961:0.012564:0.003024:0.005125:0.009223:0.003961:0.013894:0.006441:0.009207:0.003961:0.003024:0.009223:0.003961:0.005125:0.009223:0.009827:0.003961:0.005125:0.004551:0.009827:0.010326:0.005125:0.014182:0.009827:0.009223:0.005125:0.003946:0.009903:0.004747:0.003961:0.009177:0.011188:0.003961:0.010326:0.009223:0.010357:0.003991:0.008950:0.007529:0.011188:0.004188
biological DmArDs:@0.519047:0.595886:0.672253:0.595886:0.672253:0.577554:0.519047:0.577554:0.009743:0.004032:0.010751:0.004032:0.010751:0.011087:0.004032:0.010751:0.011087:0.004032:0.004704:0.011759:0.015119:0.012431:0.009743:0.011759:0.007392
These  are  proteins  directed  against  specific  cytokines :@0.519047:0.611914:0.928032:0.611914:0.928032:0.596131:0.519047:0.596131:0.006290:0.009071:0.009676:0.005715:0.009676:0.004188:0.003598:0.010175:0.004400:0.009676:0.004188:0.003598:0.010160:0.004400:0.009752:0.004974:0.009676:0.002873:0.009071:0.005715:0.004188:0.003598:0.010205:0.002873:0.004400:0.009676:0.009631:0.004974:0.009676:0.010205:0.004188:0.003598:0.010175:0.010024:0.010175:0.002873:0.009071:0.005715:0.004974:0.004188:0.003598:0.005715:0.010160:0.009676:0.009631:0.002873:0.003606:0.003606:0.009631:0.004188:0.003598:0.009631:0.007953:0.004974:0.009752:0.007439:0.002873:0.009071:0.009676:0.005866:0.004188
or their cell receptors. The most widely used biological :@0.519047:0.625768:0.928047:0.625768:0.928047:0.609986:0.519047:0.609986:0.009752:0.004400:0.006365:0.004974:0.009071:0.009676:0.002873:0.004400:0.006365:0.009631:0.009676:0.002873:0.002873:0.006365:0.004400:0.009676:0.009631:0.009676:0.010160:0.004974:0.009752:0.004400:0.005715:0.004037:0.006365:0.006290:0.009071:0.009676:0.006365:0.014030:0.009752:0.005715:0.004974:0.006365:0.012413:0.002873:0.010205:0.009676:0.002873:0.007953:0.006365:0.009041:0.005715:0.009676:0.010205:0.006365:0.010160:0.002873:0.009752:0.002873:0.009752:0.010024:0.002873:0.009631:0.010175:0.003024:0.004188
DMARDs are those inhibiting tumour necrosis factor (or :@0.519047:0.639623:0.928032:0.639623:0.928032:0.623840:0.519047:0.623840:0.011097:0.013743:0.011037:0.009026:0.011097:0.005715:0.006350:0.010175:0.004400:0.009676:0.006350:0.004974:0.009071:0.009752:0.005715:0.009676:0.006350:0.002873:0.009071:0.009071:0.002873:0.010160:0.002873:0.004974:0.002873:0.009071:0.010024:0.006350:0.004974:0.009041:0.014030:0.009752:0.009041:0.004400:0.006350:0.009071:0.009676:0.009631:0.004400:0.009752:0.005715:0.002873:0.005715:0.006350:0.004596:0.010175:0.009631:0.004974:0.009752:0.004400:0.006350:0.005428:0.009752:0.004551:0.004188
anti-TNF agents). In RA, these drugs show similar efficacy :@0.519047:0.653477:0.927972:0.653477:0.927972:0.637695:0.519047:0.637695:0.010175:0.009071:0.004974:0.002873:0.004868:0.006290:0.011037:0.007182:0.004415:0.010175:0.010024:0.009676:0.009071:0.004974:0.005715:0.005428:0.004037:0.004415:0.003266:0.009071:0.004415:0.009026:0.011037:0.004037:0.004415:0.004974:0.009071:0.009676:0.005715:0.009676:0.004415:0.010205:0.004400:0.009041:0.010024:0.005715:0.004415:0.005715:0.009071:0.009752:0.012413:0.004415:0.005715:0.002873:0.014030:0.002873:0.002873:0.010175:0.004400:0.004415:0.009676:0.004596:0.003606:0.003606:0.009631:0.010175:0.009631:0.008104:0.004188
to MTX, although the effects on radiographic progression :@0.519047:0.667332:0.928032:0.667332:0.928032:0.651549:0.519047:0.651549:0.004974:0.009752:0.003598:0.013743:0.006290:0.009056:0.004037:0.003598:0.010175:0.002873:0.004974:0.009071:0.009752:0.009041:0.010024:0.009071:0.003583:0.004974:0.009071:0.009676:0.003598:0.009676:0.004596:0.004596:0.009676:0.009631:0.004974:0.005715:0.003583:0.009752:0.009071:0.003583:0.004400:0.010175:0.010205:0.002873:0.009752:0.010024:0.004400:0.010175:0.010160:0.009071:0.002873:0.009631:0.003583:0.010160:0.004400:0.009752:0.010024:0.004400:0.009676:0.005715:0.005715:0.002873:0.009752:0.009223:0.004188
appear to be higher and responses can be achieved :@0.519047:0.681186:0.928002:0.681186:0.928002:0.665404:0.519047:0.665404:0.010175:0.010160:0.010160:0.009676:0.010175:0.004400:0.006577:0.004974:0.009752:0.006577:0.010160:0.009676:0.006577:0.009071:0.002873:0.010024:0.009071:0.009676:0.004400:0.006577:0.010175:0.009071:0.010205:0.006577:0.004400:0.009676:0.005715:0.010160:0.009752:0.009071:0.005715:0.009676:0.005715:0.006577:0.009631:0.010175:0.009071:0.006577:0.010160:0.009676:0.006577:0.010175:0.009631:0.009071:0.002873:0.009676:0.008225:0.009676:0.010357:0.004188
more rapidly. Moreover, the combination of an anti-TNF :@0.519047:0.695041:0.928017:0.695041:0.928017:0.679258:0.519047:0.679258:0.014030:0.009752:0.004400:0.009676:0.004899:0.004400:0.010175:0.010160:0.002873:0.010205:0.002873:0.007953:0.004037:0.004899:0.013743:0.009752:0.004400:0.009676:0.009752:0.008225:0.009676:0.004400:0.004037:0.004899:0.004974:0.009071:0.009676:0.004899:0.009631:0.009752:0.014030:0.010160:0.002873:0.009071:0.010175:0.004974:0.002873:0.009752:0.009071:0.004899:0.009752:0.004596:0.004899:0.010175:0.009071:0.004899:0.010175:0.009071:0.004974:0.002873:0.004868:0.006290:0.011037:0.007333:0.004188
agent  and  MTX  produces  benefits  greater  than  either :@0.519047:0.708896:0.928047:0.708896:0.928047:0.693113:0.519047:0.693113:0.010175:0.010024:0.009676:0.009071:0.004974:0.004188:0.002933:0.010175:0.009071:0.010205:0.004188:0.002933:0.013743:0.006290:0.009056:0.004188:0.002933:0.010160:0.004400:0.009752:0.010205:0.009041:0.009631:0.009676:0.005715:0.004188:0.002933:0.010160:0.009676:0.009071:0.009676:0.003606:0.003606:0.004974:0.005715:0.004188:0.002933:0.010024:0.004400:0.009676:0.010175:0.004974:0.009676:0.004400:0.004188:0.002933:0.004974:0.009071:0.010175:0.009071:0.004188:0.002933:0.009676:0.002873:0.004974:0.009071:0.009676:0.004551:0.004188
alone. In spA patients, where there is a lack of response :@0.519047:0.722750:0.928078:0.722750:0.928078:0.706967:0.519047:0.706967:0.010175:0.002873:0.009752:0.009071:0.009676:0.004037:0.004747:0.003266:0.009071:0.004747:0.007378:0.008799:0.011037:0.004747:0.010160:0.010175:0.004974:0.002873:0.009676:0.009071:0.004974:0.005715:0.004037:0.004747:0.012413:0.009071:0.009676:0.004400:0.009676:0.004747:0.004974:0.009071:0.009676:0.004400:0.009676:0.004747:0.002873:0.005715:0.004747:0.010175:0.004747:0.002873:0.010175:0.009631:0.007439:0.004747:0.009752:0.004596:0.004747:0.004400:0.009676:0.005715:0.010160:0.009752:0.009071:0.005715:0.009827:0.004188
to NsAIDs, anti-TNF therapy has been shown to improve :@0.519047:0.736605:0.928002:0.736605:0.928002:0.720822:0.519047:0.720822:0.004974:0.009752:0.005004:0.011037:0.007378:0.011037:0.003266:0.011097:0.005715:0.004037:0.005004:0.010175:0.009071:0.004974:0.002873:0.004868:0.006290:0.011037:0.007182:0.005004:0.004974:0.009071:0.009676:0.004400:0.010175:0.010160:0.007953:0.005004:0.009071:0.010175:0.005715:0.005004:0.010160:0.009676:0.009676:0.009071:0.005004:0.005715:0.009071:0.009752:0.012413:0.009071:0.005004:0.004974:0.009752:0.005004:0.002873:0.014030:0.010160:0.004400:0.009752:0.008225:0.009827:0.004188
symptoms and retard radiographic progression. :@0.519047:0.750459:0.864457:0.750459:0.864457:0.734676:0.519047:0.734676:0.005715:0.007953:0.014030:0.010160:0.004974:0.009752:0.014030:0.005715:0.004037:0.010175:0.009071:0.010205:0.004037:0.004400:0.009676:0.004974:0.010175:0.004400:0.010205:0.004037:0.004400:0.010175:0.010205:0.002873:0.009752:0.010024:0.004400:0.010175:0.010160:0.009071:0.002873:0.009631:0.004037:0.010160:0.004400:0.009752:0.010024:0.004400:0.009676:0.005715:0.005715:0.002873:0.009752:0.009071:0.004188:0.004188
A major side effect of anti-TNF therapy is an increased :@0.533335:0.764314:0.927972:0.764314:0.927972:0.748531:0.533335:0.748531:0.011188:0.003674:0.014182:0.010326:0.003069:0.009903:0.004551:0.003674:0.005866:0.003024:0.010357:0.009827:0.003689:0.009827:0.004747:0.004747:0.009827:0.009782:0.005125:0.003674:0.009903:0.004747:0.003674:0.010326:0.009223:0.005125:0.003024:0.005020:0.006441:0.011188:0.007318:0.003674:0.005125:0.009223:0.009827:0.004551:0.010326:0.010311:0.008104:0.003674:0.003024:0.005866:0.003689:0.010326:0.009223:0.003674:0.003024:0.009223:0.009782:0.004551:0.009827:0.010326:0.005866:0.009827:0.010357:0.004188
susceptibility  to infection,  particularly tuberculosis (TB). :@0.519047:0.778168:0.927987:0.778168:0.927987:0.762386:0.519047:0.762386:0.005866:0.009192:0.005866:0.009782:0.009827:0.010311:0.005125:0.003024:0.010311:0.003024:0.003024:0.003024:0.005125:0.008104:0.004188:0.002343:0.005125:0.009903:0.006516:0.003024:0.009223:0.004747:0.009827:0.009782:0.005125:0.003024:0.009903:0.009223:0.004188:0.004188:0.002313:0.010311:0.010326:0.004551:0.005125:0.003024:0.009782:0.009192:0.003024:0.010326:0.004551:0.003024:0.008104:0.006516:0.005125:0.009192:0.010311:0.009827:0.004551:0.009782:0.009192:0.003024:0.009903:0.005866:0.003024:0.005866:0.006516:0.005579:0.006441:0.008678:0.005579:0.004188:0.004188
All patients should be screened for TB before initiating :@0.519047:0.792023:0.927972:0.792023:0.927972:0.776240:0.519047:0.776240:0.011188:0.003024:0.003024:0.005866:0.010311:0.010326:0.005125:0.003024:0.009827:0.009223:0.005125:0.005866:0.005866:0.005866:0.009223:0.009903:0.009192:0.003024:0.010357:0.005866:0.010311:0.009827:0.005866:0.005866:0.009782:0.004551:0.009827:0.009827:0.009223:0.009827:0.010357:0.005866:0.004747:0.009903:0.004551:0.005866:0.006441:0.008678:0.005866:0.010311:0.009827:0.004747:0.009903:0.004551:0.009827:0.005866:0.003024:0.009223:0.003024:0.005125:0.003024:0.010326:0.005125:0.003024:0.009223:0.010175:0.004188
treatment. :@0.519047:0.805877:0.600735:0.805877:0.600735:0.790095:0.519047:0.790095:0.005125:0.004551:0.009827:0.010326:0.005125:0.014182:0.009827:0.009223:0.005125:0.004188:0.004188
Alternatives to the anti-TNF agents include agents :@0.533335:0.819732:0.928017:0.819732:0.928017:0.803949:0.533335:0.803949:0.011188:0.003024:0.005125:0.009827:0.004551:0.009223:0.010326:0.005125:0.003024:0.008376:0.009827:0.005866:0.008769:0.005125:0.009903:0.008769:0.005125:0.009223:0.009827:0.008769:0.010326:0.009223:0.005125:0.003024:0.005020:0.006441:0.011188:0.007333:0.008769:0.010326:0.010175:0.009827:0.009223:0.005125:0.005866:0.008769:0.003024:0.009223:0.009782:0.003024:0.009192:0.010357:0.009827:0.008769:0.010326:0.010175:0.009827:0.009223:0.005125:0.005866:0.004188
blocking cytokines IL1, IL6, IL17, IL12/23, co-stimulatory :@0.519047:0.833586:0.928002:0.833586:0.928002:0.817804:0.519047:0.817804:0.010311:0.003024:0.009903:0.009782:0.007590:0.003024:0.009223:0.010175:0.006365:0.009782:0.008104:0.005125:0.009903:0.007590:0.003024:0.009223:0.009827:0.005866:0.006365:0.003417:0.006985:0.008376:0.004188:0.006365:0.003417:0.006985:0.008376:0.004188:0.006365:0.003417:0.006985:0.008376:0.008376:0.004188:0.006365:0.003417:0.006985:0.008376:0.008376:0.006607:0.008376:0.008376:0.004188:0.006365:0.009782:0.009903:0.005020:0.005866:0.005125:0.003024:0.014182:0.009192:0.003024:0.010326:0.005125:0.009903:0.004551:0.008104:0.004188
molecules, as well as anti-CD20, a B lymphocyte marker.:@0.519047:0.847441:0.923814:0.847441:0.923814:0.831658:0.519047:0.831658:0.014182:0.009903:0.003024:0.009827:0.009782:0.009192:0.003024:0.009827:0.005866:0.004188:0.003266:0.010326:0.005866:0.003266:0.012564:0.009827:0.003024:0.003024:0.003266:0.010326:0.005866:0.003266:0.010326:0.009223:0.005125:0.003024:0.005020:0.012292:0.011249:0.008376:0.008376:0.004188:0.003266:0.010326:0.003266:0.008678:0.003266:0.003024:0.008104:0.014182:0.010311:0.009223:0.009903:0.009782:0.008104:0.005125:0.009827:0.003266:0.014182:0.010326:0.004551:0.007590:0.009827:0.004551:0.004188
Biological agents are considered if there is an inade-:@0.533335:0.861295:0.923799:0.861295:0.923799:0.845513:0.533335:0.845513:0.008678:0.003024:0.009903:0.003024:0.009903:0.010175:0.003024:0.009782:0.010326:0.003024:0.004899:0.010326:0.010175:0.009827:0.009223:0.005125:0.005866:0.004883:0.010326:0.004551:0.009827:0.004883:0.009782:0.009903:0.009223:0.005866:0.003024:0.010357:0.009827:0.004551:0.009827:0.010357:0.004883:0.003024:0.004747:0.004883:0.005125:0.009223:0.009827:0.004551:0.009827:0.004883:0.003024:0.005866:0.004899:0.010326:0.009223:0.004883:0.003024:0.009223:0.010326:0.010357:0.009827:0.005020
quate response to conventional therapy. In  spA, this :@0.519047:0.875277:0.927987:0.875277:0.927987:0.859494:0.519047:0.859494:0.010311:0.009192:0.010326:0.005125:0.009827:0.007605:0.004551:0.009827:0.005866:0.010311:0.009903:0.009223:0.005866:0.009827:0.007605:0.005125:0.009903:0.007605:0.009782:0.009903:0.009223:0.008376:0.009827:0.009223:0.005125:0.003024:0.009888:0.009223:0.010326:0.003024:0.007605:0.005125:0.009223:0.009827:0.004551:0.010326:0.010311:0.008104:0.004188:0.007605:0.003417:0.009223:0.004188:0.003417:0.007529:0.008950:0.011188:0.004188:0.007605:0.005125:0.009223:0.003024:0.005866:0.004188
adjustment is made after three months, whereas in RA :@0.519047:0.889259:0.928002:0.889259:0.928002:0.873476:0.519047:0.873476:0.010326:0.010357:0.003069:0.009192:0.005866:0.005125:0.014182:0.009827:0.009223:0.005125:0.005413:0.003024:0.005866:0.005413:0.014182:0.010326:0.010357:0.009827:0.005413:0.010326:0.004747:0.005125:0.009827:0.004551:0.005397:0.005125:0.009223:0.004551:0.009827:0.009827:0.005397:0.014182:0.009903:0.009223:0.005125:0.009223:0.005866:0.004188:0.005397:0.012564:0.009223:0.009827:0.004551:0.009827:0.010326:0.005866:0.005413:0.003024:0.009223:0.005413:0.009177:0.011188:0.004188
usually  after six months.  The choice of drug depends :@0.519047:0.903240:0.928002:0.903240:0.928002:0.887457:0.519047:0.887457:0.009192:0.005866:0.009192:0.010326:0.003024:0.003024:0.008104:0.004188:0.002812:0.010326:0.004747:0.005125:0.009827:0.004551:0.006985:0.005866:0.003024:0.007257:0.006985:0.014182:0.009903:0.009223:0.005125:0.009223:0.005866:0.004188:0.004188:0.002782:0.006441:0.009223:0.009827:0.006985:0.009782:0.009223:0.009903:0.003024:0.009782:0.009827:0.006985:0.009903:0.004747:0.006985:0.010357:0.004551:0.009192:0.010175:0.006985:0.010357:0.009827:0.010311:0.009827:0.009223:0.010357:0.005866:0.004188
on the safety profile and patient preference. If there is :@0.519047:0.917222:0.927987:0.917222:0.927987:0.901439:0.519047:0.901439:0.009903:0.009223:0.005261:0.005125:0.009223:0.009827:0.005261:0.005866:0.010326:0.004747:0.009827:0.005125:0.008104:0.005261:0.010311:0.004551:0.009903:0.003681:0.003681:0.003024:0.009827:0.005261:0.010326:0.009223:0.010357:0.005261:0.010311:0.010326:0.005125:0.003024:0.009827:0.009223:0.005125:0.005261:0.010311:0.004551:0.009827:0.004747:0.009827:0.004551:0.009827:0.009223:0.009782:0.009827:0.004188:0.005246:0.003417:0.004747:0.005261:0.005125:0.009223:0.009827:0.004551:0.009827:0.005261:0.003024:0.005866:0.004188
no response after six months, a switch to an alternative :@0.519047:0.931203:0.928002:0.931203:0.928002:0.915420:0.519047:0.915420:0.009223:0.009903:0.004732:0.004551:0.009827:0.005866:0.010311:0.009903:0.009223:0.005866:0.009827:0.004732:0.010326:0.004747:0.005125:0.009827:0.004551:0.004732:0.005866:0.003024:0.007257:0.004732:0.014182:0.009903:0.009223:0.005125:0.009223:0.005866:0.004188:0.004732:0.010326:0.004732:0.005866:0.012564:0.003024:0.005125:0.009782:0.009223:0.004732:0.005125:0.009903:0.004732:0.010326:0.009223:0.004732:0.010326:0.003024:0.005125:0.009827:0.004551:0.009223:0.010326:0.005125:0.003024:0.008376:0.009827:0.004188
agent can be made.:@0.519047:0.945312:0.674637:0.945312:0.674637:0.929529:0.519047:0.929529:0.010326:0.010175:0.009827:0.009223:0.005125:0.004188:0.009782:0.010326:0.009223:0.004188:0.010311:0.009827:0.004188:0.014182:0.010326:0.010357:0.009827:0.004188